Anthony Petrone
Stock Analyst at Mizuho
(4.13)
# 476
Out of 5,072 analysts
199
Total ratings
53.47%
Success rate
11.73%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Maintains: Outperform | $65 → $70 | $63.52 | +10.20% | 9 | Nov 13, 2025 | |
| ALC Alcon | Maintains: Outperform | $110 → $100 | $79.36 | +26.01% | 11 | Nov 11, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Outperform | $70 → $85 | $69.12 | +22.97% | 8 | Nov 6, 2025 | |
| RMD ResMed | Maintains: Outperform | $310 → $300 | $255.83 | +17.27% | 18 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 → $100 | $86.71 | +15.33% | 10 | Oct 31, 2025 | |
| HOLX Hologic | Downgrades: Neutral | $70 → $78 | $74.97 | +4.04% | 10 | Oct 23, 2025 | |
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $108.42 | -35.44% | 3 | Sep 25, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $81.35 | -13.95% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $58.87 | +18.91% | 6 | Aug 7, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $114.37 | +18.04% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $128.90 | +4.73% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $90 | $77.93 | +15.49% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $26.21 | -31.32% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $105.33 | -5.06% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $12.76 | -5.92% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $63.47 | +57.55% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $106.29 | +64.64% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $6.18 | +547.25% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $20.99 | -4.72% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $101.29 | -40.76% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $80.40 | -27.86% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $101.58 | +8.29% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $19.18 | -27.01% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $79.99 | +31.27% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $124.53 | +100.75% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.86 | +104.23% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $573.48 | -31.99% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $83.29 | -19.55% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $97.52 | +79.45% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.59 | +115.70% | 3 | May 13, 2020 |
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $63.52
Upside: +10.20%
Alcon
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $79.36
Upside: +26.01%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $70 → $85
Current: $69.12
Upside: +22.97%
ResMed
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $255.83
Upside: +17.27%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $90 → $100
Current: $86.71
Upside: +15.33%
Hologic
Oct 23, 2025
Downgrades: Neutral
Price Target: $70 → $78
Current: $74.97
Upside: +4.04%
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $108.42
Upside: -35.44%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $81.35
Upside: -13.95%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $58.87
Upside: +18.91%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $114.37
Upside: +18.04%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $128.90
Upside: +4.73%
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $77.93
Upside: +15.49%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $26.21
Upside: -31.32%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $105.33
Upside: -5.06%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $12.76
Upside: -5.92%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $63.47
Upside: +57.55%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $106.29
Upside: +64.64%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $6.18
Upside: +547.25%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $20.99
Upside: -4.72%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $101.29
Upside: -40.76%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $80.40
Upside: -27.86%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $101.58
Upside: +8.29%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $19.18
Upside: -27.01%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $79.99
Upside: +31.27%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $124.53
Upside: +100.75%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.86
Upside: +104.23%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $573.48
Upside: -31.99%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $83.29
Upside: -19.55%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $97.52
Upside: +79.45%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.59
Upside: +115.70%